Digital therapeutics company Pear Therapeutics is looking to integrate digital biomarkers, machine learning algorithms and sensor-based technologies into its platform thanks to new licensing deals and partnerships.
The Boston-based DTx company has inked collaboration deals with Empatica and etectRx, as well as licensing tech from KeyWise.
Specifically, Pear's collaboration with Empatica will...
The accuracy of wearables employing photoplethysmography (PPG)-based heart rate sensors may vary significantly between specific devices and activity types, but these sensors’ performances do not appear to be significantly affected by the skin tone of the wearer, according to a new study published in NPJ Digital Medicine.
The investigation, conducted by Duke University researchers among 53...
Virtual assistants and wearable technologies are starting to catch the pharma world’s attention. The industry is exploring how the new tools can be used in research, clinical trials and inpatient settings. However, obstacles including privacy compliance and data standards are still questions that the industry is grappling with, according to panelists at the MassBio forum on Using Clinical Data...
The Embrace2, a seizure monitoring wearable from Boston and Milan-based Embrace, has received an updated FDA clearance that allows it to be used by children ages six and up — the first such device to receive clearance for pediatric use.
"The fact that this is the first clearance of its kind in epilepsy highlights how difficult it is to get robust results with pediatric patients in a clinical...
With discussions on consumer data privacy again reaching a head amongst the lay press and lawmakers, it isn’t too far a stretch to wonder whether the data collected continuously through health and fitness wearables is receiving appropriate scrutiny.
During a wearables-focused panel discussion held yesterday at PULSE: The Atlantic Summit on Health Care in Boston, top names from Fitbit, Empatica,...
Empatica's Embrace, the consumer-facing wearable for epileptic seizure detection, received 510(k) clearance from the FDA last month. The wearable, which has already been used in clinical trials by pharma company Sunovion, has a long history that's led it up to this milestone.
The clearance is as a prescription, not an over-the-counter device, which means users will have to secure a prescription...
Marlborough, Massachusetts-based pharma company Sunovion will use the Empatica Embrace, a wearable device for seizure detection, in a phase 4 clinical study of Aptiom, a drug meant to reduce seizures in people with epilepsy.
“We believe that incorporating digital health technologies into traditional treatment paradigms has the potential to inform and enhance best practices and further empower...
At Boston Children's Hospital's second annual Innovator's Showcase this week, researchers and clinicians presented a number of new technology-focused offerings that are currently in use or being tested at the hospital. Here are four digital health tools that were on display at the showcase.
RNSafe -- Boston Children's FastTrack Innovation in Technology (FIT) team is testing a new app, called...
Cambridge, Massachusetts and Milan, Italy-based Empatica is crowdfunding a new wristworn tracker device, Embrace, which brings clinically validated tracking methods to the consumer market. The technology has an initial primary focus on epilepsy, but is also usable for activity, stress and sleep tracking in healthy individuals and will gradually add use cases for other chronic conditions including...
